The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical implications of recurring mutations in myxoid liposarcoma (MLS).
 
Prapassorn Thirasastr
No Relationships to Disclose
 
Heather Y. Lin
No Relationships to Disclose
 
Elise F Nassif
No Relationships to Disclose
 
Wei-Lien Wang
No Relationships to Disclose
 
Dejka M. Araujo
Research Funding - Adaptimmune (Inst); GlaxoSmithKline (Inst); Immatics (Inst)
 
Robert S. Benjamin
Stock and Other Ownership Interests - Gilead Sciences (I); Johnson & Johnson (I)
 
Anthony Paul Conley
Consulting or Advisory Role - AADi; Applied Clinical Intelligence; Bayer; Deciphera; Deciphera; Genentech; Guidepoint Global; InhibRx; Medscape; Nektar; Novartis; OncLive; Schlesinger Associates
Research Funding - Bavarian Nordic (Inst); Chordoma Foundation (Inst); EpicentRx (Inst); Ignyta (Inst); InhibRx (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); MedImmune (Inst); NantHealth (Inst); NCI (Inst)
Travel, Accommodations, Expenses - Genentech
 
J Andrew Andrew Livingston
Consulting or Advisory Role - Foghorn Therapeutics
Research Funding - Repare Therapeutics (Inst)
Other Relationship - Guidepoint Global
 
Joseph Aloysius Ludwig
Research Funding - Boehringer Ingelheim (Inst); Ikena Oncology (Inst)
 
Shreyaskumar Patel
Consulting or Advisory Role - Adaptimmune; BioAtla; Daiichi Sankyo; Deciphera; GlaxoSmithKline; Rain Oncology
Research Funding - Blueprint Medicines (Inst); HUTCHMED (Inst); Rain Therapeutics (Inst)
 
Ravin Ratan
Stock and Other Ownership Interests - Johnson & Johnson/Janssen (I); Medtronic (I)
Honoraria - Peerview; touchIME
Consulting or Advisory Role - Epizyme
Research Funding - Ayala Pharmaceuticals (Inst); Bayer; Epizyme; SpringWorks Therapeutics (Inst); SpringWorks Therapeutics (Inst)
Travel, Accommodations, Expenses - SpringWorks Therapeutics; SpringWorks Therapeutics
 
Vinod Ravi
Stock and Other Ownership Interests - AstraZeneca; Merck; Moderna Therapeutics; Pfizer; TRACON Pharma
Honoraria - UpToDate
Consulting or Advisory Role - AADi; Daiichi Sankyo; Gerson Lehrman Group; Guidepoint Inc
Research Funding - AADi (Inst); Athenex (Inst); Novartis (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties from Uptodate
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Maria Alejandra Zarzour
No Relationships to Disclose
 
Xiao Zhou
No Relationships to Disclose
 
Neeta Somaiah
Stock and Other Ownership Interests - JNJ (I); Pfizer (I)
Consulting or Advisory Role - AADi; Bayer; Blueprint Medicines; Boehringer Ingelheim; Deciphera; Epizyme
Research Funding - Ascentage Pharma; AstraZeneca/MedImmune (Inst); Daiichi Sankyo/Lilly; Deciphera; GlaxoSmithKline; Karyopharm Therapeutics